Receipt of formal meeting minutes from the FDA confirming key elements for two proposed Phase 3 pivotal trials indicates regulatory progress and alignment with the FDA. Positive outcome of the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback